Anesthesia Quality Improvement and Patients With Planned ICU Admission

February 24, 2025 updated by: Dong-Xin Wang, Peking University First Hospital

Effects of Anesthesia Quality Improvement on Outcomes of Patients With Planned ICU Admission: a Prospective Pre-post Intervention Study

Intensive care unit (ICU) is an important part of perioperative management for high-risk patients but is associated with higher medical costs. Improper ICU admission may produce overtreatment without beneficial effects. In clinical practice, delayed recovery after general anesthesia is a common indication for ICU admission after surgery. The concept of Enhanced Recovery After Surgery recommends early extubation. The investigators suppose that, for patients with planned ICU admission after elective surgery, implementing anesthesia quality improvement including extubation in the operating room will reduce the rate of ICU admission after surgery without increasing complications.

Study Overview

Detailed Description

Intensive care unit (ICU) is an important part of perioperative management for high-risk patients but is associated with higher medical costs. Improper ICU admission may produce overtreatment without beneficial effects. Studies found that immediate ICU admission after surgery did not reduce the perioperative mortality. Some authors suggested that the indication of ICU admission should be the occurrence of postoperative complications, which will reasonably reduce the use of medical resources.

In clinical practice, delayed recovery after general anesthesia is a common indication for ICU admission after surgery. Old age, high ASA grade, respiratory complications, long duration surgery, large-volume fluid infusion, and use of vasopressors were main factors associated with delayed recovery. The concept of Enhanced Recovery After Surgery recommends early extubation after surgery. Studies showed that, for patients after organ transplantation, immediate extubation in the operating room can shorten hospital stay and reduce medical costs, without increasing mortality.

The investigators suppose that, for patients with planned ICU admission after elective surgery, implementing anesthesia quality improvement including extubation in the operating room will reduce the rate of ICU admission after surgery without increasing postoperative complications.

Study Type

Interventional

Enrollment (Actual)

1500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100034
        • Peking University First Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥18 years.
  • Scheduled to undergo elective surgery.
  • Planned ICU admission after surgery.

Exclusion Criteria:

  • Refused to participate in the study.
  • ICU admission before surgery.
  • Unexpected ICU admission.
  • Other conditions that are considered unsuitable for study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Routine anesthesia care
• Implementing anesthesia management according to current routine practice.
• Implementing anesthesia management according to current routine practice.
Experimental: Improved anesthesia care
  • Encourage regional anesthesia or combined regional-general anesthesia.
  • Encourage goal-directed fluid therapy, lung-protective ventilation, and active warming during surgery.
  • Encourage extubation in the operating room at the end of surgery.
  • Encourage multimodal analgesia after surgery.
  • Encourage strict indication for ICU admission after surgery.
  • Encourage regional anesthesia or combined regional-general anesthesia.
  • Encourage goal-directed fluid therapy, lung-protective ventilation, and active warming during surgery.
  • Encourage extubation in the operating room at the end of surgery.
  • Encourage multimodal analgesia after surgery.
  • Encourage strict indication for ICU admission after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative complication
Time Frame: Up to 30 days after surgery
Postoperative complications are defined as newly occurred medical conditions that are considered harmful to patients' recovery and require therapeutic intervention, that is grade II or higher on Clavin-Dindo classification.
Up to 30 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay in hospital after surgery
Time Frame: Up to 30 days after surgery
Length of stay in hospital after surgery
Up to 30 days after surgery
Rate of ICU admission
Time Frame: On the 1 day of surgery
Rate of ICU admission
On the 1 day of surgery
Incidence of postoperative delirium
Time Frame: Up to 5 days after surgery
Delirium is assessed with the Three-dimensional Confusion Assessment Method (3D-CAM) twice daily (8:00-10:00 am and 18:00-20:00 pm).
Up to 5 days after surgery
Medical costs during hospitalization
Time Frame: Up to 30 days after surgery
Medical costs during hospitalization
Up to 30 days after surgery
Rate of delayed neurocognitive recovery
Time Frame: up to 7 days after surgery
Cognitive function is assessed with the Montreal Cognitive Assessment (MoCA) before surgery and at discharge. A decrease of 1 standard deviation (SD) or more from baseline is defined as the development of delayed neurocognitive recovery.
up to 7 days after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
All-cause 30-day mortality
Time Frame: Up to 30 days after surgery
All-cause 30-day mortality
Up to 30 days after surgery
Length of stay in ICU after surgery
Time Frame: Up to 30 days after surgery
Length of stay in ICU after surgery
Up to 30 days after surgery
Duration of mechanical ventilation
Time Frame: up to 30 days after surgery
Duration of mechanical ventilation
up to 30 days after surgery
Rate of ICU re-admission
Time Frame: Up to 30 days after surgery
ICU re-admission is defined as ICU admission from the general wards after surgery
Up to 30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dong-Xin Wang, MD, PhD, Peking University First Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

July 31, 2024

Study Completion (Actual)

August 31, 2024

Study Registration Dates

First Submitted

November 15, 2022

First Submitted That Met QC Criteria

November 22, 2022

First Posted (Actual)

November 23, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 24, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Routine anesthesia care

Subscribe